Moderna (MRNA) PT Lowered to $40 at Barclays
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.65 --0%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Moderna (NASDAQ: MRNA) to $40.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson as Shares Remain Undervalued
- Applied Industrial Technologies (AIT) PT Raised to $400 at DA Davidson
- Cellebrite (CLBT) PT Lowered to $15 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
